SHARx says PBM rebids may not fix employer drug costs

The company argues employers should test revenue models, transparency and post-launch outcomes, not just discounts and rebate guarantees, as pharmacy spending takes a larger share of health benefit budgets.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.